Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7342 p350
26 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
No smoking


Stop smoking services unlikely to meet targets

NHS smoking cessation services are unlikely to meet the Government’s targets for reducing smoking prevalence in England, a study published online suggests (BMJ Online First PDF (50K)).

In 2003–04, smoking cessation services in Northumberland and Tyne and Wear reduced smoking rates by 0.1–0.3 per cent. This rate of reduction would be unlikely to reduce prevalence in the region by more than 0.8–2.4 per cent by 2010, the research suggests.

The author of the study, Eugene Milne, deputy medical director, Northumberland Tyne and Wear Strategic Health Authority, argues that, because current targets do not propose a narrowing of the health inequality gap between rich and poor areas, Government targets themselves are insufficient for the poorest communities.“To narrow health gaps in England it is not sufficient simply to be better at delivering smoking cessation,” Dr Milne says. “Bupropion and nicotine replacement are among the most cost effective of all health care interventions, but comprehensive restriction of smoking in all workplaces works better. Both are needed and deprived areas need more of both.”

Miriam Armstrong, chief executive of PharmacyHealthLink, told The Journal that research consistently demonstrates that smokers from lower socioeconomic groups are more pharmacologically nicotine dependent than others and need more support to help them stop successfully, which may create a role for pharmacists. “To help reduce the inequalities gap, the NHS stop smoking services could use pharmacists to help treat less dependent smokers and thus focus their own resources more on targeting and supporting the smokers who need more help to stop,” she explained.

Back to Top


©The Pharmaceutical Journal